Insulin glargine, recombinant Subcutaneous and Zoledronic acid
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Zoledronic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Zoledronic Acid (Bone Health)
- Insulin glargine, recombinant Subcutaneous-Zoledronic Acid (Zometa)
- Insulin glargine, recombinant Subcutaneous-Zoledronic Acid Injection
- Insulin glargine, recombinant Subcutaneous-Zoledronic Acid Injection Concentrate
- Insulin glargine, recombinant Subcutaneous-Zoledronic acid Intravenous
- Insulin glargine, recombinant Subcutaneous-Zoledronic Acid IV
- Zoledronic acid-Insulin glulisine
- Zoledronic acid-Insulin Glulisine (Cartridges and Pens)
- Zoledronic acid-Insulin Glulisine (Vials)
- Zoledronic acid-Insulin glulisine Subcutaneous
- Zoledronic acid-Insulin human inhaled Inhalation
- Zoledronic acid-Insulin human regular Injection